SCHEMBL21089028

SCHEMBL21089028

Nc1ccc(CF)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2B P18089 1/20 0.49
IDO1 P14902 3/20 0.38
MAPT P10636 3/20 0.38
TSHR P16473 3/20 0.38
AGXT P21549 2/20 0.38
MAPK1 P28482 2/20 0.38
GAA P10253 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
GFER P55789 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TAAR1 Q96RJ0 1/20 0.33
AKR1B1 P15121 1/20 0.33
GLA P06280 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31175766 0.83 ADRA2B (0.50) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL26037690 0.83 ADRA2B (0.50) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL7239671 0.81 TAAR1 (0.54) ADRA2BMAPTMAPK1TDP1TAAR1
SCHEMBL12844067 0.81 TAAR1 (0.38) ADRA2BIDO1MAPTTSHRMAPK1
SCHEMBL4332045 0.81 ADRA2B (0.49) ADRA2BIDO1MAPTTSHRAGXT
Hydrochloric Acid SCHEMBL1161200 0.79 ADRA2B (0.47) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL377462 0.79 ADRA2B (0.47) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL5923845 0.79 ADRA2B (0.47) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL22384566 0.79 ADRA2B (0.47) ADRA2BIDO1MAPTTSHRAGXT
SCHEMBL12983255 0.79 ADRA2B (0.47) ADRA2BIDO1MAPTTSHRAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558446-B1 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC IMMUNE SA (CH) 2019-06-12 EP disclosed